Clinical Trials Browser

Phase 2 × Head and Neck Neoplasms × dacomitinib × Clear all

NCT00768664 2021-02-09

Open-Label Trial Of Oral PF-00299804 By Continuous Dosing In Patients With Recurrent Or Metastatic Head And Neck Squamous Cell Cancer

Phase 2 Completed

69 enrolled 18 charts

Head and Neck Neoplasms, Recurrence

NCT01449201 2014-09-30

PF-00299804 in Patients With Head and Neck Squamous Cell Carcinoma

Phase 2 Completed

Carcinoma, Squamous Cell, Head and Neck Neoplasms